Urteste SA (URT) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.185x

Based on the latest financial reports, Urteste SA (URT) has a cash flow conversion efficiency ratio of -0.185x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-4.41 Million ≈ $-1.21 Million USD) by net assets (zł23.79 Million ≈ $6.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Urteste SA market cap and net worth for the company's overall valuation and market capitalisation.

Urteste SA - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Urteste SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Urteste SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Urteste SA ranked by their cash flow conversion efficiency. See debt repayment capacity of Urteste SA to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Blue Shark Power System SA
PA:MLBSP
N/A
Canuc Resources Corp
V:CDA
-0.981x
Fidelity Special Values
LSE:FSV
0.010x
Lleidanetworks Serveis Telematics SA
MC:LLN
0.270x
Redflow Ltd
AU:RFX
-0.849x
111 Inc
NASDAQ:YI
-3.363x
Precio Fishbone AB (publ)
ST:PRCO-B
0.044x
Carboclor
BA:CARC
0.037x

Annual Cash Flow Conversion Efficiency for Urteste SA (2019–2025)

The table below shows the annual cash flow conversion efficiency of Urteste SA from 2019 to 2025. View Urteste SA (URT) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 zł34.58 Million
≈ $9.52 Million
zł10.64 Million
≈ $2.93 Million
0.308x +235.68%
2024-12-31 zł24.11 Million
≈ $6.64 Million
zł-5.47 Million
≈ $-1.50 Million
-0.227x -18.22%
2023-12-31 zł27.74 Million
≈ $7.64 Million
zł-5.32 Million
≈ $-1.46 Million
-0.192x +71.57%
2022-12-31 zł5.62 Million
≈ $1.55 Million
zł-3.79 Million
≈ $-1.04 Million
-0.675x -154.05%
2021-12-31 zł9.69 Million
≈ $2.67 Million
zł-2.57 Million
≈ $-708.19K
-0.266x +73.22%
2020-12-31 zł1.37 Million
≈ $375.68K
zł-1.35 Million
≈ $-372.56K
-0.992x -197.46%
2019-12-31 zł1.20 Million
≈ $328.95K
zł-398.48K
≈ $-109.67K
-0.333x --

About Urteste SA

WAR:URT Poland Biotechnology
Market Cap
$18.14 Million
zł65.93 Million PLN
Market Cap Rank
#25524 Global
#257 in Poland
Share Price
zł43.20
Change (1 day)
-1.82%
52-Week Range
zł28.40 - zł70.20
All Time High
zł180.00
About

Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.